Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,668 USD | -0,30% | -14,77% | -26,79% |
13/03 | Transcript : Gossamer Bio, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 07:30 AM | |
12/03 | Gossamer Bio kondigt benoeming in Raad van Bestuur aan | CI |
Vakgebied
Aantal werknemers: 135
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Faheem Hasnain
CEO | Chief Executive Officer | 65 | 25-10-15 |
Bryan Giraudo
DFI | Director of Finance/CFO | 48 | 07-05-18 |
Chief Tech/Sci/R&D Officer | - | 03-10-23 | |
Richard Aranda
CTO | Chief Tech/Sci/R&D Officer | 64 | 01-02-18 |
Christian Waage
ADM | Chief Administrative Officer | 57 | 01-08-17 |
Bob Smith
PRN | Corporate Officer/Principal | - | 05/12 |
Jeff Boerneke
LAW | General Counsel | - | 01-01-21 |
Deanna Weber
HRO | Human Resources Officer | - | 01-04-18 |
Caryn Peterson
LAW | General Counsel | 65 | 01-01-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Faheem Hasnain
CEO | Chief Executive Officer | 65 | 25-10-15 |
Thomas Daniel
BRD | Director/Board Member | 69 | 01-01-18 |
Skye Drynan
BRD | Director/Board Member | - | 11/03 |
John Quisel
BRD | Director/Board Member | 53 | 28/11 |
Russell Cox
BRD | Director/Board Member | 60 | 19-12-18 |
Sandra Milligan
BRD | Director/Board Member | - | 10-06-21 |
Renée Galá
BRD | Director/Board Member | 52 | 19-12-18 |
Steven Nathan
BRD | Director/Board Member | - | 11/03 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 226 218 652 | 221 155 248 ( 97,76 %) | 0 | 97,76 % |
Bedrijfsgegevens
Gossamer Bio, Inc.
3013 Science Park Road Suite 200
92121, San Diego
+858 684 1300
http://www.gossamerbio.comBedrijven van de groep
Naam | Categorie en sector |
---|---|
Gossamer Bio Services, Inc.
Gossamer Bio Services, Inc. Pharmaceuticals: MajorHealth Technology Part of Gossamer Bio, Inc., Gossamer Bio Services, Inc. operates as an American biopharmaceutical company which discovers, develops and commercializes immunology-based therapeutics. The private company is located in the US. |
Pharmaceuticals: Major
|
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-26,79% | 151 mln. | |
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |
- Beurs
- Aandelen
- Koers GOSS
- Onderneming Gossamer Bio, Inc.